Active — Not RecruitingNot Applicable

RCT of Mobile Apps & FitBit v. Usual Care

United States107 participantsStarted 2017-05-31

Plain-language summary

This is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subject is 18 years or older
✓. Subject speaks English
✓. Subject owns a smart phone
✓. Subject is scheduled to undergo surgery for a GI cancer (pancreatic, hepatic, gastric, small bowel, colon, or rectal cancers)

Exclusion criteria

✕. Physician deems the subject is unable to complete the study due to documented dementia
✕. Subject is undergoing emergent surgery
✕. Subject has sepsis from another source
✕. Physician deems the subject is unable to complete the study due to documented alcohol and/or drug abuse

What they're measuring

Readmission rate

Timeframe: 30 days

Trial details

NCT IDNCT03623464

SponsorWeill Medical College of Cornell University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06

View on ClinicalTrials.gov More Pancreatic Cancer trials